Prostate cancer decision aids 'make no difference'

A systematic review finds no compelling rationale to use them

Current decision aids developed for prostate cancer screening can decrease decisional conflict but ultimately have no effect on whether men decide to undergo screening, a systematic review has found.

prostate cancer ribbon

An international team of researchers conducted a meta-analysis of 19 randomised con-trolled trials covering more than 12,700 men (average age 59) that compared decision aids for PSA testing with usual care.

The studies — conducted from 1999 to 2017 — tested 12 different decision aids, including booklets of up to 28